Axios @axios
The companies say their recombinant protein-based vaccine could ultimately serve as a universal booster — able to boost immunity regardless of the vaccination first received. https://t.co/jQW6Ai1J3t — PolitiTweet.org
Created
Mon May 17 13:16:08 +0000 2021
Likes
42
Retweets
13
Source
TweetDeck
View Raw Data
JSON DataView on Twitter
Likely Available
Axios @axios
The companies say their recombinant protein-based vaccine could ultimately serve as a universal booster — able to boost immunity regardless of the vaccination first received. https://t.co/jQW6Ai1J3t — PolitiTweet.org